Ingram Robert Alexander
10% owner at Clearside Biomedical, Inc.; Director at WOLF; Director at REGN, and 5 more
- Sold, on record
- $9.2M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Jun 7, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 8
- Filed as an executive or holder
Companies
- Clearside Biomedical, Inc.10% owner
- WOLFWOLFSPEED, INC.Director
- REGNREGENERON PHARMACEUTICALS, INC.Director
- EWEdwards Lifesciences CorpDirector
- BHCBausch Health Companies Inc.Director
- ALLERGAN INCDirector
- LOWLOWES COMPANIES INCDirector
- OSI PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- OSI PHARMACEUTICALS INC75,000 shares
- EW47,090 shares
- ALLERGAN INC18,000 shares
- LOW16,000 shares
- BHC9,872 shares
- WOLF3,750 shares
- REGN1,379 shares
- Clearside Biomedical, Inc.138 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BHCUnusualFeb 28, 2011 2011
Sold 9,872 shares at $40.00 ($395k)
Ingram Robert Alexander, Director
Sold 100% of holdings ($395k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale EWPlan not statedMay 9, 2011 +70 days
Sold 10,000 shares at $87.79 ($878k)
Ingram Robert Alexander, Director
Sold 17.8% of holdings ($4.9M position)46,302 shares leftFiling
- 3 Form 4 sale EWUnusualMay 25, 2012 +382 days
Sold 15,000 shares at $87.72 ($1.3M)
Ingram Robert Alexander, Director
Sold 28.9% of holdings ($4.5M position)36,856 shares left3x usual sizeFiling
- 4 Form 4 sale EWUnusualJul 31, 2014 +797 days
Sold 12,500 shares at $90.26 ($1.1M)
Ingram Robert Alexander, Director
Sold 29% of holdings ($3.9M position)30,541 shares leftFirst sale on recordFiling
- 5 Form 4 sale REGNUnusualMay 27, 2015 +300 days
Sold 1,379 shares at $513.39 ($708k)
Ingram Robert Alexander, Director
Sold 47.9% of holdings ($1.5M position)1,500 shares leftFirst sale on recordFiling
- 6 Form 4 sale WOLFPlan not statedDec 1, 2015 +188 days
Sold 3,750 shares at $27.67 ($104k)
Ingram Robert Alexander, Director
Sold 7.1% of holdings ($1.5M position)48,846 shares leftFirst sale on recordFiling
- 7 Form 4 sale Clearside Biomedical, Inc.Plan not statedJun 7, 2016 +189 days
Sold 69 shares at $7.00 ($483)
Ingram Robert Alexander, 10% owner
Sold 0% of holdings ($11.7M position)1.7M shares leftFirst sale on recordFiling
- 8 Form 4 sale Clearside Biomedical, Inc.Plan not statedJun 7, 2016 same day
Sold 69 shares at $7.00 ($483)
Ingram Robert Alexander, 10% owner
Sold 0% of holdings ($11.7M position)1.7M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2016 | Jun 7, 2016 | Clearside Biomedical, Inc. | 10% owner | Form 4 sale | 69 | $483 | 0.0% | Plan not stated | SEC |
| Jun 7, 2016 | Jun 7, 2016 | Clearside Biomedical, Inc. | 10% owner | Form 4 sale | 69 | $483 | 0.0% | Plan not stated | SEC |
| Dec 1, 2015 | Dec 3, 2015 | WOLF | Director | Form 4 sale | 3,750 | $104k | 7.1% | Plan not stated | SEC |
| May 27, 2015 | May 27, 2015 | REGN | Director | Form 4 sale | 1,379 | $708k | 47.9% | Unusual | SEC |
| Jul 31, 2014 | Aug 1, 2014 | EW | Director | Form 4 sale | 12,500 | $1.1M | 29.0% | Unusual | SEC |
| May 25, 2012 | May 25, 2012 | EW | Director | Form 4 sale | 15,000 | $1.3M | 28.9% | Unusual | SEC |
| May 9, 2011 | May 11, 2011 | EW | Director | Form 4 sale | 10,000 | $878k | 17.8% | Plan not stated | SEC |
| Feb 28, 2011 | Mar 3, 2011 | BHC | Director | Form 4 sale | 9,872 | $395k | 100.0% | Unusual | SEC |
| Feb 15, 2011 | Feb 16, 2011 | ALLERGAN INC | Director | Form 4 sale | 10,800 | $795k | 42.6% | Unusual | SEC |
| Nov 30, 2010 | Dec 1, 2010 | EW | Director | Form 4 sale | 5,000 | $332k | 8.2% | Plan not stated | SEC |
| Nov 16, 2010 | Nov 17, 2010 | EW | Director | Form 4 sale | 4,590 | $298k | 7.0% | Plan not stated | SEC |
| May 27, 2010 | May 27, 2010 | LOW | Director | Form 4 sale | 8,000 | $197k | 100.0% | Unusual | SEC |
| Feb 22, 2010 | Feb 23, 2010 | ALLERGAN INC | Director | Form 4 sale | 7,200 | $424k | 22.2% | Plan not stated | SEC |
| May 21, 2008 | May 22, 2008 | LOW | Director | Form 4 sale | 8,000 | $191k | 100.0% | Unusual | SEC |
| Mar 28, 2007 | Mar 29, 2007 | OSI PHARMACEUTICALS INC | Director | Form 4 sale | 2,000 | $64k | 9.6% | Plan not stated | SEC |
| Mar 28, 2007 | Mar 29, 2007 | OSI PHARMACEUTICALS INC | Director | Form 4 sale | 9,685 | $315k | 31.7% | Unusual | SEC |
| Mar 28, 2007 | Mar 29, 2007 | OSI PHARMACEUTICALS INC | Director | Form 4 sale | 13,615 | $446k | 30.8% | Unusual | SEC |
| Mar 27, 2007 | Mar 29, 2007 | OSI PHARMACEUTICALS INC | Director | Form 4 sale | 49,700 | $1.6M | 52.9% | Unusual | SEC |